Cohen Mardge H, French Audrey L, Benning Lorie, Kovacs Andrea, Anastos Kathryn, Young Mary, Minkoff Howard, Hessol Nancy A
Department of Medicine, Cook County Hospital, Chicago, Illinois, USA.
Am J Med. 2002 Aug 1;113(2):91-8. doi: 10.1016/s0002-9343(02)01169-5.
PURPOSE: To examine changes in the causes of death and mortality in women with human immunodeficiency virus (HIV) infection in the era of combination antiretroviral therapy. METHODS: Among women with, or at risk of, HIV infection, who were enrolled in a national study from 1994 to 1995, we used an algorithm that classified cause of death as due to acquired immunodeficiency syndrome (AIDS) or non-AIDS causes based on data from death certificates and the CD4 count. Poisson regression models were used to estimate death rates and to determine the risk factors for AIDS and non-AIDS deaths. RESULTS: Of 2059 HIV-infected women and 569 who were at risk of HIV infection, 468 (18%) had died by April 2000 (451 HIV-infected and 17 not infected). Causes of death were available for 428 participants (414 HIV-infected and 14 not infected). Among HIV-infected women, deaths were classified as AIDS (n = 294), non-AIDS (n = 91), or indeterminate (n = 29). The non-AIDS causes included liver failure (n = 19), drug overdose (n = 16), non-AIDS malignancies (n = 12), cardiac disease (n = 10), and murder, suicide, or accident (n = 10). All-cause mortality declined an average of 26% per year (P = 0.03) and AIDS-related mortality declined by 39% per year (P = 0.01), whereas non-AIDS-related mortality remained stable (10% average annual decrease, P = 0.73). Factors that were independently associated with non-AIDS-related mortality included depression, history of injection drug use with hepatitis C infection, cigarette smoking, and age. CONCLUSION: A substantial minority (20%) of deaths among women with HIV was due to causes other than AIDS. Our data suggest that to decrease mortality further among HIV-infected women, attention must be paid to treatable conditions, such as hepatitis C, depression, and drug and tobacco use.
目的:研究在联合抗逆转录病毒治疗时代,感染人类免疫缺陷病毒(HIV)的女性的死因及死亡率变化。 方法:在1994年至1995年参与一项全国性研究的感染HIV或有感染风险的女性中,我们使用一种算法,根据死亡证明数据和CD4计数将死因分类为获得性免疫缺陷综合征(AIDS)或非AIDS原因。采用泊松回归模型估计死亡率,并确定AIDS和非AIDS死亡的危险因素。 结果:在2059名感染HIV的女性和569名有HIV感染风险的女性中,到2000年4月,468人(18%)已经死亡(451名感染HIV,17名未感染)。428名参与者(414名感染HIV,14名未感染)的死因明确。在感染HIV的女性中,死亡被分类为AIDS(n = 294)、非AIDS(n = 91)或不确定(n = 29)。非AIDS原因包括肝功能衰竭(n = 19)、药物过量(n = 16)、非AIDS恶性肿瘤(n = 12)、心脏病(n = 10)以及谋杀、自杀或意外(n = 10)。全因死亡率平均每年下降26%(P = 0.03),与AIDS相关的死亡率每年下降39%(P = 0.01),而非AIDS相关死亡率保持稳定(平均每年下降10%,P = 0.73)。与非AIDS相关死亡率独立相关的因素包括抑郁、有丙型肝炎感染的注射吸毒史、吸烟和年龄。 结论:感染HIV的女性中,相当一部分(20%)死亡是由AIDS以外的原因导致的。我们的数据表明,为进一步降低感染HIV女性的死亡率,必须关注可治疗的疾病,如丙型肝炎、抑郁以及药物和烟草使用。
Front Public Health. 2023
J Womens Health (Larchmt). 2022-8
JAMA Netw Open. 2019-5-3
Am J Public Health. 2002-1
J Am Med Womens Assoc (1972). 2001
Cad Saude Publica. 2000
J Urban Health. 2000-6